Friday, January 28, 2022

Medication Guide - 1/28/2022

 

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More

Drug Name Active Ingredient Form;Route Appl. No. Company Date
Skyrizi Risankizumab-Rzaa INJECTABLE;INJECTION 761105 ABBVIE INC 01/21/2022
Tecentriq Atezolizumab INJECTABLE;INJECTION 761034 GENENTECH INC 01/21/2022

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment